TC
| |
TCG Crossover Management, LLC13F | |
| TCG Crossover Management, LLC | |
| Last update 2025-05-14 | 37 Stocks (0 new) |
| Value $733.00 Mil | Turnover 2 % |
TCG Crossover Management, LLC Top Holdings of 2025-03-31
View Full List
| Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CGON | CG Oncology Inc | 3,670,206 | 89,883.4 | 0% | 12.260 | 0% | 4.820 | +31.80% | -6.21% | 2,050.5 | Biotechnology | |
COGT | Cogent Biosciences Inc | 6,964,375 | 41,716.6 | 0% | 5.690 | 0% | 6.120 | +186.05% | +57.69% | 1,714.8 | Biotechnology | |
CNTA | Centessa Pharmaceuticals PLC | 2,890,816 | 41,569.9 | 0% | 5.670 | 0% | 2.160 | +32.18% | -4.12% | 2,145.9 | Biotechnology | |
MLYS | Mineralys Therapeutics Inc | 2,470,265 | 39,227.8 | 0% | 5.350 | 0% | 3.810 | +2.87% | +10.64% | 887.7 | Biotechnology | |
OCUL | Ocular Therapeutix Inc | 5,319,148 | 38,989.4 | 0% | 5.320 | 0% | 3.340 | +51.31% | +34.84% | 1,834.3 | Biotechnology | |
ABVX | Abivax SA | 6,056,596 | 37,853.7 | 0% | 5.160 | 0% | 9.550 | +62.76% | +38.52% | 643.6 | Biotechnology | |
SVRA | Savara Inc | 12,362,205 | 34,243.3 | 0% | 4.670 | 0% | 7.160 | -24.92% | -25.41% | 395.8 | Biotechnology | |
DYN | Dyne Therapeutics Inc | 2,650,150 | 27,720.6 | 0% | 3.780 | 0% | 2.330 | -1.71% | -61.08% | 1,298.0 | Biotechnology | |
DNTH | Dianthus Therapeutics Inc | 1,501,624 | 27,239.5 | 0% | 3.720 | 0% | 4.670 | +1.42% | -4.86% | 667.0 | Biotechnology | |
TYRA | Tyra Biosciences Inc | 2,898,103 | 26,952.4 | +45.70% | 3.680 | +1.15% | 5.450 | +17.11% | -23.67% | 564.2 | Biotechnology |
TCG Crossover Management, LLC's Historical Top Holdings Breakdowns
TCG Crossover Management, LLC's Top Stock Picks
View Full List
| Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
|---|---|---|---|---|---|---|---|---|---|---|---|
SLNO | Soleno Therapeutics Inc | 2025-03-31 | Reduce Reduce | -1.21% | 42.54 ($48.69) 71.99 | $86.97 | 78.62% | Reduce -50% | 275,000 | -275,000 | |
TYRA | Tyra Biosciences Inc | 2025-03-31 | Add Add | +1.15% | 9.3 ($12.94) 16.73 | $10.61 | -18.01% | Add 45.7% | 2,898,103 | 909,000 | |
KROS | Keros Therapeutics Inc | 2025-03-31 | Sold Out Sold Out | -0.85% | 10.15 ($11.61) 16.1 | $13.79 | 18.78% | Sold Out | 0 | -550,000 | |
AMLX | Amylyx Pharmaceuticals Inc | 2025-03-31 | Add Add | +0.63% | 3 ($3.56) 4.15 | $8.21 | 130.62% | Add 27.99% | 5,943,812 | 1,300,000 | |
IRON | Disc Medicine Inc | 2025-03-31 | Reduce Reduce | -0.13% | 49.64 ($55.6) 63.82 | $59.38 | 6.80% | Reduce -4.46% | 465,257 | -21,700 | |
RAPT | RAPT Therapeutics Inc | 2025-03-31 | Reduce Reduce | -0.01% | 8.4 ($9.83) 13.76 | $11.70 | 19.02% | Reduce -0.34% | 1,636,275 | -45,060 | |
EWTX | Edgewise Therapeutics Inc | 2024-12-31 | Sold Out Sold Out | -4.78% | 26.63 ($31.91) 36.62 | $13.39 | -58.04% | Sold Out | 0 | -2,112,984 | |
UPB | Upstream Bio Inc | 2024-12-31 | New Buy New Buy | +4.38% | 16.11 ($22.33) 27.39 | $10.64 | -52.35% | New holding | 2,801,763 | 2,801,763 | |
TNGX | Tango Therapeutics Inc | 2024-12-31 | New Buy New Buy | +3.24% | 2.79 ($4.6) 7.46 | $6.77 | 47.17% | New holding | 10,736,000 | 10,736,000 | |
DNTH | Dianthus Therapeutics Inc | 2024-12-31 | New Buy New Buy | +3.20% | 20.27 ($25.68) 29.9 | $20.74 | -19.24% | New holding | 1,501,624 | 1,501,624 |
TCG Crossover Management, LLC Total Holding History ($B)
TCG Crossover Management, LLC's Asset Allocation
TCG Crossover Management, LLC Past Portfolios
| Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
|---|---|---|---|---|
Top Ranked Articles
- 1
TCG Crossover Management, LLC's Hypothetical Growth since 2025-03-31
TCG Crossover Management, LLC's Yearly Returns
| Year | Portfolio % | % | Excess Gain % |
|---|
TCG Crossover Management, LLC's Holdings Heat Map
Size field:
TCG Crossover Management, LLC's Holdings Bubble Chart
TCG Crossover Management, LLC News
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers